EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.4.50 | expressed in Hep-G2 cells | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.4.50 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.4.50 | hepatocarcinoma cell | the serum GPI-PLD activities, the GPI-PLD protein expression levels, and the protein and mRNA levels of GPI-PLD in hepatocellular carcinoma are decreased by 40%, 60%, and 56%, respectively | Homo sapiens | - |
3.1.4.50 | hepatoma cell | - |
Homo sapiens | - |
3.1.4.50 | liver | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.4.50 | 3-O-alpha-D-galactosaminyl-2-phosphatidyl-L-chiro-inositol + H2O | - |
Homo sapiens | ? | - |
? | |
3.1.4.50 | glycosylphosphatidylinositol-anchored placental alkaline phosphatase + H2O | - |
Homo sapiens | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.4.50 | glycosylphosphatidylinositol-specific phospholipase D | - |
Homo sapiens |
3.1.4.50 | GPI-PLD | - |
Homo sapiens |
3.1.4.50 | GPI-specific phospholipase D | - |
Homo sapiens |